BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7088170)

  • 1. Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis.
    Bicknell RJ; Leng G
    Nature; 1982 Jul; 298(5870):161-2. PubMed ID: 7088170
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous opioid inhibition of the release of oxytocin from the isolated rat neurohypophysis during high-frequency stimulation of the pituitary stalk.
    Wammack R; Racké K
    Neurosci Lett; 1988 Sep; 92(1):114-8. PubMed ID: 3185974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interleukin-1 beta on the secretion of oxytocin and vasopressin from the isolated rat neurohypophysis.
    Christensen JD; Hansen EW; Fjalland B
    Pharmacol Toxicol; 1990 Jul; 67(1):81-3. PubMed ID: 2395821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of opiates on release of vasopressin from isolated rat neurohypophysis.
    Christensen JD; Fjalland B
    Acta Pharmacol Toxicol (Copenh); 1982 Feb; 50(2):113-6. PubMed ID: 7072501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid inhibition of secretion from oxytocin and vasopressin nerve terminals following selective depletion of neurohypophysial catecholamines.
    Bicknell RJ; Zhao BG; Chapman C; Heavens RP; Sirinathsinghji DJ
    Neurosci Lett; 1988 Nov; 93(2-3):281-6. PubMed ID: 3241653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrotoxin and 4-aminopyridine potentiate neurohypophysial hormone secretion during low frequency electrical stimulation.
    Bondy CA; Russell JT
    Brain Res; 1988 Jun; 453(1-2):397-400. PubMed ID: 2456835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency-dependent effects of activation and inhibition of protein kinase C on neurohypophysial release of oxytocin and vasopressin.
    Racké K; Burns F; Haas B; Niebauer J; Pitzius E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):617-24. PubMed ID: 2770888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of potassium channel blockers on neurohypophysial release of oxytocin and vasopressin. Evidence for frequency-dependent interaction with the endogenous opioid inhibition of oxytocin release.
    Racké K; Altes U; Baur AM; Hobbach HP; Jost D; Schäfer J; Wammack R
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):560-6. PubMed ID: 2854213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The content of vasopressin and oxytocin in the hypothalamus and neurohypophysis of pinealectomized male rats.
    Juszczak M; Guzek JW
    Acta Physiol Pol; 1983; 34(1):41-6. PubMed ID: 6637529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynorphin (1-8) inhibits stimulated release of oxytocin but not vasopressin from isolated neurosecretory endings of the rat neurohypophysis.
    Falke N
    Neuropeptides; 1988; 11(4):163-7. PubMed ID: 2901684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin and oxytocin neurohypophysial content under conditions of beta-adrenergic blockade in euhydrated and dehydrated rats: further studies.
    Janus J; Guzek JW
    Exp Clin Endocrinol; 1988 Mar; 91(1):78-84. PubMed ID: 3371417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids.
    Racké K; Ritzel H; Trapp B; Muscholl E
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):56-65. PubMed ID: 7110370
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible fatigue of stimulus-secretion coupling in the rat neurohypophysis.
    Bicknell RJ; Brown D; Chapman C; Hancock PD; Leng G
    J Physiol; 1984 Mar; 348():601-13. PubMed ID: 6716296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
    Bondy CA; Gainer H; Russell JT
    Endocrinology; 1988 Apr; 122(4):1321-7. PubMed ID: 2894296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activators of protein kinase C potentiate electrically stimulated hormone secretion from the rat's isolated neurohypophysis.
    Bondy CA; Gainer H
    Neurosci Lett; 1988 Jun; 89(1):97-101. PubMed ID: 3165164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
    Knepel W; Meyer DK
    J Physiol; 1983 Aug; 341():507-15. PubMed ID: 6620188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release.
    Zhao BG; Chapman C; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of beta-adrenergic blockade on the hypothalamic and neurohypophysial vasopressin and oxytocin content in pinealectomized male rats.
    Guzek JW; Juszczak M
    Exp Clin Endocrinol; 1987 Mar; 89(1):97-104. PubMed ID: 2885209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin F2 alpha stimulates vasopressin and oxytocin release from isolated rat neurointermediate lobe.
    Bojanowska E; Guzek JW
    Exp Clin Endocrinol; 1989; 94(3):375-82. PubMed ID: 2630314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.